CJC-1295 / Ipamorelin Blend (5 mg / 5 mg) – Research peptide
- 🔬 Tested laboratory quality
- 💎 >99% purity
- 🚚 Fast & secure shipping
€74.99
Product information "CJC-1295 / Ipamorelin Blend (5 mg / 5 mg) – Research peptide"
Combined peptide formulation for studying synergistic signaling mechanisms in growth hormone release and receptor activation.
General Description
The CJC-1295 / Ipamorelin Blend combines two synthetic peptides used in scientific studies to analyze peptide-mediated secretion mechanisms. CJC-1295 is a modified GHRH analogue (Growth Hormone Releasing Hormone), while Ipamorelin is a synthetic GHRP agonist (Growth Hormone Releasing Peptide). Together, they serve as an experimental model for investigating parallel signaling pathways, receptor activation, and peptide synergy within endocrine systems.
Chemical Properties
- Purity: ≥ 99 % (HPLC-tested)
- Form: lyophilized powder
- Content: 5 mg CJC-1295 + 5 mg Ipamorelin
- Sequences:
- CJC-1295: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂
- Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
- Solubility: water-soluble after reconstitution
Research Relevance
In preclinical research models, the CJC-1295 / Ipamorelin Blend is used to study combined peptide signaling, receptor cascades, and endocrine feedback mechanisms. It is intended exclusively for fundamental research and the structural analysis of synergistic peptide effects at the molecular level.
Storage & Handling
Store in a cool (2 – 8 °C), dry place. After reconstitution, aliquot and store at −20 °C to preserve the stability of both peptide components.
Certificate of Analysis (COA)
Each batch of the CJC-1295 / Ipamorelin Blend is verified by HPLC and mass spectrometry analyses. The corresponding COA is available for download per batch.
Notice & Disclaimer
This product is intended for research purposes only. Not for human or animal use, and not suitable for diagnostic or therapeutic applications.
Login
You may also be interested in:
